Results
Table 1 depicts a comparison of serological indicators in OF patients versus NC In heart failure patients, 60 patients comprising 35 men and 25 women (M:F=1.4:1) aged (mean±SD=65.06±12.32 years) the serological indicator CK-MB (20.53±10.45μg/L vs 0.96±0.11μg/L, P<0.05), MYO (924.4±201.3μg/L vs 42.41±4.94μg/L, P<0.001), cTNI (1.123±0.35μg/L vs 0.023±0.011μg/L, P<0.05) and BNP (2753±576.1ng/L vs 0.96±0.11 ng/L, P<0.001)were higher than 30 NC comprising 14 men and 16 women (M:F=7:8) aged (mean±SD=60.23±13.99 years). In renal failure patients, 40 patients comprising 27 men and 13 women (M:F=2.08:1) aged (mean±SD=61.22±9.38 years) the serological indicator BUN (21.06±2.13mmol/L vs 5.58±0.33mmol/L, P<0.001), Cr (21.06±2.13μmol/L vs 5.58±0.33μmol/L, P<0.01), CysC (282.5±56.56mg/L vs 72.62±5.73mg/L, P<0.01), β2-MG (9.74±1.48mg/L vs 1.94±0.18mg/L, P<0.001)were also significantly higher than 30 NC comprising 14 men and 16 women (M:F=7:8) aged (mean±SD=60.23±13.99 years), respectively.
The OF patients